Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306339 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Binh Thang Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Public Health, University of Medicine and Pharmacy, Hue University, Hue City, Thua Thien Hue Province, Vietnam. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hue University.
Abstract (Originalsprache)
Introduction
The COmprehensive Score for Financial Toxicity (COST) has proven to be a reliable tool for quantifying the impact of financial toxicity (FT) in patients with cancer in clinical and public health settings. However, the COST has not yet been validated in Vietnam. Therefore, we aimed to evaluate its reliability and validity among Vietnamese patients with cancer.
Methods
A cross-sectional study was conducted in a sample of 300 patients with cancer aged 27–95 years (mean: 58.5±11.2) in a tertiary hospital. The COST was translated into Vietnamese and English and adjusted to suit the local culture. Reliability was evaluated using Cronbach’s alpha and McDonald’s omega coefficients. The construct and convergent validities were also assessed.
Results
The COST demonstrated good internal consistency and reliability (Cronbach’s alpha = 0.913; McDonald’s omega = 0.915). The exploratory factor analysis revealed two factors that explained 64.9% of the variance. The adjusted fit indices indicated a good fit of the model (χ 2 (39) = 67.78, p = 0.003; standardized root mean squared residual = 0.042; Tucker–Lewis index = 0.971; comparative fit index = 0.979; root mean square error of approximation = 0.061, 90% confidence interval = 0.035–0084). Higher COST scores were significantly correlated with higher health-related quality of life (EQ-5D-5L utility score: r = 0.21, p = 0.002; EQ VAS: r = 0.28, p < 0.001). Multivariate quantile regression analysis revealed that female sex, rural residence, and unstable job/unemployment were associated with lower COST scores. There was no statistically significant difference in other factors, including clinical factors (types of cancer, staging, and treatment modalities).
Conclusions
The COST is reliable and valid, making it suitable for assessing FT severity in Vietnamese patients with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Public Health, University of Medicine and Pharmacy, Hue University, Hue City, Thua Thien Hue Province, Vietnam.
- Undergraduate Training Office, University of Medicine and Pharmacy, Hue University, Hue City, Thua Thien Hue Province, Vietnam.
- Oncology Centre, Hue Central Hospital, Hue City, Thua Thien Hue Province, Vietnam.
- Faculty of Public Health, Da Nang University of Medical Technology and Pharmacy, Da Nang City, Vietnam.
ORCID-Profile: Binh Thang Tran
Förderung
- Hue University
Zitieren
APA
Tran, B. T., Le, D. D., Nguyen, T. G., Nguyen, M. T., Nguyen, M. H., Dang, C. K., & Tran, D. T. (2024). Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer. PLOS ONE. https://doi.org/10.1371/journal.pone.0306339
Vancouver
Tran BT, Le DD, Nguyen TG, Nguyen MT, Nguyen MH, Dang CK, et al. Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer. PLOS ONE. 2024. doi:10.1371/journal.pone.0306339
BibTeX
@article{Tran2024,
author = {Tran, Binh Thang and Le, Dinh Duong and Nguyen, Thanh Gia and Nguyen, Minh Tu and Nguyen, Minh Hanh and Dang, Cao Khoa and Tran, Dinh Trung},
title = {Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306339}
}
EUVIMED